NEWS
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Top Lists
Gustavo Borjas
University of Chicago - Chicago / United States
Medical and Health Sciences / Immunology
AD Scientific Index ID: 5473636
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Gustavo Borjas's MOST POPULAR ARTICLES
1-)
Protofibril–fibril interactions inhibit amyloid fibril assembly by obstructing secondary nucleationF Hasecke, C Niyangoda, G Borjas, J Pan, G Matthews, M Muschol, ...Angewandte Chemie 133 (6), 3053-3058, 2021252021
2-)
Kinetic transition in amyloid assembly as a screening assay for oligomer-selective dyesJ Barton, DS Arias, C Niyangoda, G Borjas, N Le, S Mohamed, M MuscholBiomolecules 9 (10), 539, 2019152019
3-)
A Phase II Study of Durvalumab for Bacillus Calmette-Guerin (BCG) Unresponsive Urothelial Carcinoma In Situ of the BladderR Li, WJ Sexton, J Dhillon, A Berglund, S Naidu, G Borjas, K Rose, Y Kim, ...Clinical Cancer Research 29 (19), 3875-3881, 202332023
4-)
Preliminary results from phase Ib/II neoadjuvant CG0070 and nivolumab (N) for cisplatin (C)-ineligible muscle invasive bladder cancer (MIBC).R Li, PE Spiess, WJ Sexton, SM Gilbert, MA Poch, JM Pow-Sang, J Zhang, ...Journal of Clinical Oncology 40 (16_suppl), 4574-4574, 202232022
5-)
RNA polymerase efficiently transcribes through DNA‐scaffolded, cooperative bacteriophage repressor complexesY Lu, Z Voros, G Borjas, C Hendrickson, K Shearwin, D Dunlap, L FinziFEBS letters 596 (16), 1994-2006, 202222022
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept